Breaking
🌏 NMPA

Estado Actual y Acciones para Impulsar la Investigación Clínica en México: 2025

This whitepaper discusses the current state and future actions to enhance clinical research in Mexico by 2025.

Estado Actual y Acciones para Impulsar la Investigación Clínica en México: 2025


# Executive Summary This whitepaper outlines the current landscape and strategic actions needed to advance clinical research in Mexico by 2025. Key findings include: - An analysis of the clinical research ecosystem in Mexico, highlighting challenges and opportunities. - Recommendations for integrating digital health to boost investment and economic development. - The role of universities in enhancing clinical research capabilities and training. - Ethical considerations and financing in clinical research. - The importance of patient participation and collaboration with the pharmaceutical industry and CROs.

Related Articles

Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies
NewsMay 5, 2026

Cryoport Q1 2026 Results: Revenue Jumps 26% Supporting Record 766 Clinical Trials and 21 Commercial Cell Gene Therapies

Dr. Priya Sharma
Ascidian Therapeutics Completes ACDN-01 Dose Escalation in STELLAR Phase 1/2 Trial for Stargardt Disease
NewsMay 5, 2026

Ascidian Therapeutics Completes ACDN-01 Dose Escalation in STELLAR Phase 1/2 Trial for Stargardt Disease

Kenji Watanabe
Quiver Bioscience Receives NIH HEAL Initiative Grant for QV-2421 Chronic Pain Therapy Clinical Trials
NewsMay 5, 2026

Quiver Bioscience Receives NIH HEAL Initiative Grant for QV-2421 Chronic Pain Therapy Clinical Trials

Dr. Mei Lin
Lunai Bioworks Raises $20 Million to Acquire CNS Drug Delivery Technology for Alzheimer's Treatment
NewsMay 5, 2026

Lunai Bioworks Raises $20 Million to Acquire CNS Drug Delivery Technology for Alzheimer's Treatment

Dr. Yuki Tanaka